The financing direction was already expected; the pricing is the new information. TTM had already announced the proposed Epiq Solutions acquisition, and this filing confirms the debt-funded structure rather than changing the transaction itself. The company priced $500 million of senior notes at a 6.750% coupon, with closing expected on September 24, 2026.
| Financing component | Amount / terms |
|---|---|
| Senior notes | $500M at 6.750%, due 2034 (Item 7.01; Pricing Release) |
| Incremental term loan A | $300M (Item 7.01) |
| Incremental term loan B | $800M (Item 7.01) |
| Total planned new financing | $1.6B (Item 7.01) |
| Epiq purchase price | $1.1B cash (Item 7.01) |
The transaction is now more financially committed, but not cheaper. The planned $1.6 billion of new financing exceeds the stated $1.1 billion purchase price, with the excess available for fees, expenses, corporate purposes, and potentially reducing revolver borrowings. The notes are senior unsecured obligations guaranteed by subsidiaries supporting TTM’s existing secured facilities. 〔0〕
Net read: confirmation with a clear leverage trade-off, not a fresh acquisition surprise. Relative to the standing expectation that Epiq would be funded with incremental debt, the filing is mostly in line; the meaningful update is the 6.750% fixed cost and the completed financing mix. It improves certainty around the acquisition but adds interest expense and debt obligations, leaving the event mixed rather than an incremental positive surprise. The notes sale remains subject to customary closing conditions. 〔1〕
Read the original 8-K on SEC EDGAR ↗